Blood Collection in Strong Acidic Citrate Anticoagulant Used in a Study of Dietary Influence on Basal tPA Activity

Summary Tissue plasminogen activator (tPA) activity in blood and blood plasma has been difficult to determine because it is unstable, especially in subjects with high levels of plasminogen activator inhibitor type 1 (PAI-1). We have attempted to stabilize the tPA activity by collecting 9 volumes of blood in 1 volume acidic citrate buffer which immediately lowers the pH of the blood. At final blood pH of 4.9 to 6.3, consistent and high tPA activity levels were found. One acidic citrate buffer composition, 0.5 mol/1 citrate buffer pH 4.0, resulted in final blood pH 5.5, tPA half-life of 10 days and an acceptably low degree of haemolysis. This anticoagulant composition was selected for more extensive evaluation and was used to collect blood plasma samples from 29 volunteers in the morning after a 10-minute bed rest. Basal tPA activity, mean and SD, was 0.47 ±0.21 IU/ml. After donating of the first blood sample, 10 of the volunteers entered into a 24-hour fast after which they donated a second sample. During the fast, the basal tPA activity increased from 0.34 ±0.21 to 0.47 ±0.23 IU/ml (p = 0.05) and the PAI-1 activity decreased from 11.4±11.6 to 6.3±8.9 U/ml (p = 0.04).

[1]  M. Alessi,et al.  Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. , 1988, Blood.

[2]  B. Winblad,et al.  Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay. , 1986, Clinical chemistry.

[3]  M. Alessi,et al.  Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. , 1986, Metabolism: clinical and experimental.

[4]  E. Kruithof,et al.  Release of vascular plasminogen activator (v‐PA) after venous stasis: electrophoretic—zymographic analysis of free and complexed v‐PA , 1985, British journal of haematology.

[5]  M. Blombäck,et al.  The role of the fibrinolytic system in deep vein thrombosis. , 1985, The Journal of laboratory and clinical medicine.

[6]  B. Wiman,et al.  Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. , 1983, Thrombosis research.

[7]  B. Wiman,et al.  Plasminogen activator release during venous stasis and exercise as determined by a new specific assay. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[8]  B. Norrman,et al.  A sensitive assay for tissue plasminogen activator. , 1982, Thrombosis research.

[9]  C. Kluft Studies on the Fibrinolytic System in Human Plasma: Quantitative Determination of Plasminogen Activators and Proactivators , 1979, Thrombosis and Haemostasis.

[10]  I. Nilsson,et al.  Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis. , 1972, Acta chirurgica Scandinavica.

[11]  R. Biggs,et al.  Observations on fibrinolysis; experimental activity produced by exercise or adrenaline. , 1947, Lancet.